Blue Sky Capital Consultants Group, Inc. Moderna, Inc. Transaction History
Blue Sky Capital Consultants Group, Inc.
- $153 Billion
- Q1 2025
A detailed history of Blue Sky Capital Consultants Group, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Blue Sky Capital Consultants Group, Inc. holds 15,119 shares of MRNA stock, worth $405,189. This represents 0.28% of its overall portfolio holdings.
Number of Shares
15,119
Previous 14,563
3.82%
Holding current value
$405,189
Previous $606 Million
29.22%
% of portfolio
0.28%
Previous 0.36%
Shares
2 transactions
Others Institutions Holding MRNA
# of Institutions
875Shares Held
255MCall Options Held
24MPut Options Held
31.3M-
Vanguard Group Inc Valley Forge, PA40.4MShares$1.08 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$685 Million0.07% of portfolio
-
Baillie Gifford & CO24.9MShares$669 Million0.64% of portfolio
-
State Street Corp Boston, MA17.8MShares$476 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA7.46MShares$200 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $10.5B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...